Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Transl Res. 2011 Feb 8;157(6):326–331. doi: 10.1016/j.trsl.2011.01.006

Figure 2.

Figure 2

Representation of the interaction between autoantibodies and IRF5 and IRF7 genotype upon serum IFN-α levels in SLE patients. Bars on the graph represent median serum IFN-α levels in a group of SLE patients defined by the labels on the graph. “Risk” refers to subjects who carry IRF5 or IRF7 polymorphisms associated with SLE susceptibility in case-control studies, and “non-risk” refers to subjects who lack these variants.